OLIVENOL® plus+ is the only product with hydroxytyrosol that has been shown in human clinical studies to have therapeutic effects. Studies found it reduced V-LDL cholesterol levels and inflammatory markers for rheumatoid arthritis. Additional studies showed it improved quality of life for osteoarthritis patients by over 20%, increased protection against free radicals, and improved severe skin conditions for all subjects within 8 months.

1. OLIVENOL® plus+ is the only Hydroxytyrosol product with
proven therapeutic effects seen in human clinical studies.
Beneficial effects Details of OLIVENOL® Research
 In a 6 month clinical trial, OLIVENOL® caused a significant
reduction in V-LDL levels in male and female patients.
Reduced  High V-LDL levels substantially raise the risk of coronary
cholesterol artery disease and heart attacks.
 In a clilnical trial of rheumatoid arthritis patients, daily
OLIVENOL® capsules significantly reduced inflammatory
Reduced mediators.
OLIVENOL® significantly reduced levels of C-reactive
inflammation 
protein and homocysteine, both of which have been
implicated in cardiovascular disease.
 A OLIVENOL® clinical study demonstrated that daily
Osteoarthritis almost 70% of patients with osteoarthritis reported a
greater than 20% improvement in their quality of live with
OLIVENOL®.
 A clinical study of OLIVENOL® showed that the supplement
Increased Protection rapidly increases the body’s capability to defend itself from
against Free Radicals harmful free radicals and oxidative stress, both are
underlying causes of 100’s of human diseases.
 In a clinical trial of OLIVENOL® patients with sever skin
conditions including plaque psoriasis, allergic contact
Severe Skin Disorders dermatitis, erythema nodosum, and seborrheic dermatitis.
 Within 8 months of treatment, all subjects with skin
ailments showed major improvement.